The effect of bevacizumab on human malignant melanoma cells with functional VEGF/VEGFR2 autocrine and intracrine signaling loops.
about
Metabolic impact of anti-angiogenic agents on U87 glioma cellsMorpholino-Mediated Isoform Modulation of Vascular Endothelial Growth Factor Receptor-2 (VEGFR2) Reduces Colon Cancer Xenograft Growth.Combined therapy with thrombospondin-1 type I repeats (3TSR) and chemotherapy induces regression and significantly improves survival in a preclinical model of advanced stage epithelial ovarian cancer.BRAF Inhibition Stimulates Melanoma-Associated Macrophages to Drive Tumor GrowthA novel engineered VEGF blocker with an excellent pharmacokinetic profile and robust anti-tumor activityVascular endothelial growth factor directly stimulates tumour cell proliferation in non-small cell lung cancer.A systematic review and meta-analysis of randomized trials on the role of targeted therapy in the management of advanced gastric cancer: Evidence does not translate?Release of endothelial cell associated VEGFR2 during TGF-β modulated angiogenesis in vitroGastrointestinal cancer cells treatment with bevacizumab activates a VEGF autoregulatory mechanism involving telomerase catalytic subunit hTERT via PI3K-AKT, HIF-1α and VEGF receptorsEffect of tumor microenvironment on tumor VEGF during anti-VEGF treatment: systems biology predictionsIdentification of a Novel Pathogenic Germline KDR Variant in Melanoma.Combinatorial strategies based on CRAd-IL24 and CRAd-ING4 virotherapy with anti-angiogenesis treatment for ovarian cancer.Apatinib inhibits VEGF signaling and promotes apoptosis in intrahepatic cholangiocarcinoma.Cancer subclonal genetic architecture as a key to personalized medicine.Etoposide-Bevacizumab a new strategy against human melanoma cells expressing stem-like traits.Autocrine VEGF signaling promotes cell proliferation through a PLC-dependent pathway and modulates Apatinib treatment efficacy in gastric cancer.Molecular insights into melanoma brain metastases.Long-term efficiency of mesenchymal stromal cell-mediated CD-MSC/5FC therapy in human melanoma xenograft model.Triazole RGD antagonist reverts TGFβ1-induced endothelial-to-mesenchymal transition in endothelial precursor cells.Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integrationPilot assessment of vascular endothelial growth factor receptors and trafficking pathways in recurrent and metastatic canine subcutaneous mast cell tumours.
P2860
Q28539644-C1CF44CD-42CE-4E40-BC44-0A8B71721773Q34774917-09926A21-B06C-438F-B1D0-F8729D15A7DBQ35039333-38548FF2-E3E8-42A2-B65F-FBED3A0469A5Q35251663-235BA08B-B7F1-445C-BB02-D760C48CDDACQ35604265-F3E78BA9-E54A-4802-9F81-36974C9AA4E4Q35939630-E484E305-F4B2-4B90-9B0D-51C4445477D9Q36215991-B3ACF8CC-F473-4A53-9B34-6EEB2A13F3A5Q36257821-0109C5BA-5D52-474E-8343-E0EED847CECFQ36395933-9B36A2BF-E88D-4CC2-8EE9-DA6C4241BAE6Q36901312-41F0053A-8A61-49E5-AA51-643D0F91EEDDQ36902033-A322308D-2C4B-4C30-91A3-EF35A556855CQ37045403-8503548B-D379-41CF-8B38-7D4E94BBA6F3Q37086246-BAC7A593-739F-496C-A48E-75C0581E34DAQ37448116-53BFA855-E7BD-40CD-816B-29A00E1BBF04Q37588253-FFEBC952-ACC9-43B5-9156-5631A7B3B9DFQ37707033-F10F7901-959C-43E2-AFC5-BF3A61A5C2ACQ38764364-1C1F4DB0-0A24-4E1D-9F7B-1FBAD4936EDFQ38972307-9FA50447-710A-4A7B-A25D-FCD027EE99CEQ40926459-9AC3E5CE-164E-4FA9-A333-3BB9F500CE32Q41879186-700BC66F-D619-4B87-903B-DAA337737F75Q42682714-A938ACE2-4354-4F88-AC9C-C4B1376ED235
P2860
The effect of bevacizumab on human malignant melanoma cells with functional VEGF/VEGFR2 autocrine and intracrine signaling loops.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The effect of bevacizumab on h ...... nd intracrine signaling loops.
@ast
The effect of bevacizumab on h ...... nd intracrine signaling loops.
@en
type
label
The effect of bevacizumab on h ...... nd intracrine signaling loops.
@ast
The effect of bevacizumab on h ...... nd intracrine signaling loops.
@en
prefLabel
The effect of bevacizumab on h ...... nd intracrine signaling loops.
@ast
The effect of bevacizumab on h ...... nd intracrine signaling loops.
@en
P2093
P2860
P356
P1433
P1476
The effect of bevacizumab on h ...... nd intracrine signaling loops.
@en
P2093
Brenda L Coomber
Craig Peters
Jodi Morrison
Karolina Skowronski
Una Adamcic
P2860
P304
P356
10.1593/NEO.11948
P577
2012-07-01T00:00:00Z